Magdalena Szopa
About
In The Last Decade
Magdalena Szopa
31 papers receiving 321 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 140
- Surgery 133
- Endocrinology, Diabetes and Metabolism 101
- Genetics 100
- Physiology 44
Countries citing papers authored by Magdalena Szopa
This map shows the geographic impact of Magdalena Szopa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Szopa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Szopa more than expected).
Fields of papers citing papers by Magdalena Szopa
This network shows the impact of papers produced by Magdalena Szopa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Szopa. The network helps show where Magdalena Szopa may publish in the future.
Co-authorship network of co-authors of Magdalena Szopa
This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Szopa. A scholar is included among the top collaborators of Magdalena Szopa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Szopa. Magdalena Szopa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 24 | |
| 7 | 5 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 11 | |
| 11 | 15 | |
| 12 | 8 | |
| 13 | 2 | |
| 14 | 11 | |
| 15 | 70 | |
| 16 | 9 | |
| 17 | 38 | |
| 18 | 8 | |
| 19 | Inhibitor dehydrogenazy 11beta-hydrosteroidowej: nowy cel w farmakoterapii zespołu metabolicznego | 1 |
| 20 | Wisfatyna - nowa adipokina | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.